Cadrenal Therapeutics, Inc.
CVKD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937993
In the last 90 days, Cadrenal Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 19 institutions reported holding it in 13F filings for Q2 2026, worth $379.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Cadrenal Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q1 2026
- Shares held
- 113.7K
- +22.6K (+24.8%) vs. Q1 2026
- Total value
- $379.6K
- −$80.5K (−17.5%) vs. Q1 2026
- New holders
- 6
- 4 more added
- Sold out
- 7
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CVKD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $379.6K |
| Q1 2026 | 20 | $460.1K |
| Q4 2025 | 20 | $823.9K |
| Q3 2025 | 20 | $1.57M |
| Q2 2025 | 17 | $823.9K |
| Q1 2025 | 16 | $1.22M |
| Q4 2024 | 10 | $215.5K |
| Q3 2024 | 2 | $68 |
| Q2 2024 | 9 | $165.0K |
| Q1 2024 | 10 | $1.04M |
| Q4 2023 | 6 | $407.5K |
| Q3 2023 | 9 | $751.9K |
| Q2 2023 | 3 | $429 |
| Q1 2023 | 3 | $1.34K |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Cadrenal Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 50,137 | $167.5K | 0.00% | +4,936+10.9% | Added |
| HRT Financial LP | 29,055 | $97.0K | 0.00% | +29,055 | New |
| Geode Capital Management, LLC | 19,024 | $63.5K | 0.00% | −2,602−12.0% | Reduced |
| Vanguard Fiduciary Trust Co | 8,311 | $27.8K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 1,285 | $4.29K | 0.00% | +1,285 | New |
| Tower Research Capital LLC (TRC) | 1,282 | $4.28K | 0.00% | +889+226.2% | Added |
| UBS Group AG | 1,112 | $3.71K | 0.00% | +1,109+36,966.7% | Added |
| Grove Bank & Trust | 1,000 | $3.34K | 0.00% | +1,000 | New |
| Morgan Stanley | 706 | $2.36K | 0.00% | +606+606.0% | Added |
| Clearstead Advisors, LLC | 650 | $2.17K | 0.00% | +650 | New |
| Quest 10 Wealth Builders, Inc. | 380 | $1.27K | 0.00% | +380 | New |
| Advisor Group Holdings, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 150 | $501 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 99 | $331 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 93 | $311 | 0.00% | +93 | New |
| Archer Investment Corp | 35 | $117 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 30 | $100 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 25 | $84 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 5 | $17 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −5,496−100.0% | Sold out |
| Cygnus Capital Advisors, LLC | 0 | $0 | 0.00% | −1,492−100.0% | Sold out |
| RWM Asset Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |